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ABSTRACT
OBJECTIVE: To analyze the pneumococcal meningitis incidence rates in the State of 
São Paulo, Brazil, by age group, municipalities and micro-regions, as well as the spatial 
distribution of pneumococcal meningitis incidence rates among children under 5 years old 
in the pre- (2005–2009) and post-vaccination (2011–2013) periods and its associations with 
socioeconomic variables and vaccination coverage.
METHODS: The data source was the Brazilian Notifiable Diseases Information System. For 
the pre- and post-vaccination periods, thematic maps were built for pneumococcal meningitis 
incidence in under-5 children, by São Paulo state micro-regions, vaccination coverage and 
socioeconomic variables, using QGIS 2.6.1 software. Scan statistics performed by the SatScan 9.2 
software were used to analyze spatial and spatiotemporal clusters in São Paulo municipalities 
and micro-regions. A Bayesian inference for latent Gaussian model with zero-inflated Poisson 
model through the integrated nested Laplace approximation was used in the spatial analysis 
to evaluate associations between pneumococcal meningitis incidence rates and socioeconomic 
variables of interest in São Paulo micro-regions.
RESULTS: From 2005 to 2013, 3,963 pneumococcal meningitis cases were reported in São 
Paulo. Under-5 children were the most affected in the whole period. In the post-vaccination 
period, pneumococcal meningitis incidence rates decreased among this population, particularly 
among infants (from 4.17/100,000 in 2005 to 2.54/100,000 in 2013). Two clusters were found in 
pre-vaccination – one of low risk for pneumococcal meningitis, in the northwest of the state 
(OR = 0.45, p = 0.0003); and another of high risk in the southeast (OR = 1.62, p = 0.0000). In the 
post-vaccination period, only a high-risk cluster remained, in the southeast (RR = 1.97, p = 0.0570). 
In Bayesian analysis, wealth was the only variable positively associated to pneumococcal 
meningitis (RR = 1.026, 95%CI 1.002–1.052).
CONCLUSIONS: Pneumococcal meningitis is probably underdiagnosed and underreported 
in São Paulo. Differentiated rates of pneumococcal meningitis diagnosis and reporting in each 
microregion, according to the São Paulo Index of Social Responsibility, might explain our results.
DESCRIPTORS: Meningitis, Pneumococcal, prevention & control. Pneumococcal Vaccines, 
supply & distribution. Vaccination Coverage. Spatial Analysis. Geographic Information 
Systems, utilization. 
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INTRODUCTION
Streptococcus pneumoniae may cause serious life-threatening invasive diseases, such as 
pneumococcal meningitis (PM), sepsis and bacteremic pneumonia, as well as less serious 
but more common non-invasive diseases, such as non-bacteremic pneumonia and acute 
otitis media. Children aged ≤ 2 years, older adults, and persons of any age with chronic 
conditions are particularly affected1.
Pneumococcal disease (PD) is a major cause of morbidity and mortality, particularly in 
developing countries. Crowded living conditions, early weaning, environmental pollution, 
smoking, presence of comorbidities and low socioeconomic status are risk factors for PD, 
especially when associated with each other and within age groups of greater risk, making 
regions with the lowest human development indexes (HDI) the ones with the highest 
pneumococcal disease incidence2.
The introduction of pneumococcal conjugate vaccines into childhood immunization 
programs resulted in a substantial reduction of invasive pneumococcal disease (IPD) 
incidence rates in countries with high vaccination coverage3. Universal childhood 
immunization with the 10-valent pneumococcal conjugate vaccine (PCV10) was introduced 
into the Brazilian National Immunization Program in 2010. The evaluation of the burden of 
pneumococcal disease, including PM, before and after the introduction of pneumococcal 
vaccine is important for assessing the impact of the vaccination program4,5.
This study aimed to analyze the spatial distribution of PM incidence rates in under-5 children 
in the state of São Paulo (SP) before (2005–2009) and after (2011–2013) PCV10 introduction 
into universal childhood immunization. Associations between the PM distribution in 
SP administrative micro-regions and socioeconomic variables and vaccination coverage 
were analyzed through spatial statistical methods. Finally, the occurrence of spatial and 
spatiotemporal clusters in São Paulo municipalities and micro-regions was analyzed using 
geoprocessing techniques.
METHODS
This is a population-based ecological study, using secondary data from the Brazilian 
Notifiable Diseases Information System (SINAN – Sistema de Informação de Agravos de 
Notificação) for meningitis, in the state of São Paulo, from January 2005 to December 2013. 
SINAN is a nationwide information system, free for use in the public domain, aimed at 
recording and processing data on mandatory reporting diseases in all levels of health care 
services, in both public and private sectors. Data were retrieved from SINAN database 
using the 10th revision of the International Classification of Diseases (CID-10) code for 
pneumococcal meningitis (PM – G00.1)6.
Data on PCV10 coverage in São Paulo from 2010 to 2013 were collected from the Department 
of Informatics of the Brazilian Unified Health System (DATASUS)7. Vaccine coverage was 
defined as the number of third PCV10 doses administered to children aged < 1 year, divided 
by the estimated target population in a given area and year, multiplied by 100.
The 2010 São Paulo Index of Social Responsibility (IPRS – Índice Paulista de Responsabilidade 
Social) was used as a socioeconomic variable in analyzing the 63 administrative micro-
regions and the 645 municipalities of São Paulo8. The IPRS is a composed index that, 
in addition to the HDI dimensions (income per capita, longevity, and education level), 
includes updated administrative information to detect changes in the living conditions 
in periods shorter than the 10 years that separate the Brazilian demographic censuses, 
the source of information composing the municipal HDI. The IPRS allows for detailing 
the living conditions in São Paulo cities, a cornerstone for planning public policies. The 
IPRS is divided into five groups, in which five is the group with the lowest wealth and 
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the worst social indicators and one is the group with the highest wealth and the best 
social indicators8.
For analyzing the 63 São Paulo micro-regions, data from the municipalities were grouped 
according to the same criteria and dimensions of the municipal IPRS.
Descriptive Analysis
The PM incidence rates in under-5 children according to São Paulo municipalities 
and micro-regions were calculated based on SINAN data and the resident population 
estimated by the Brazilian Institute of Geography and Statistics (IBGE)9. The 2000 
census data was used for the period from 2005 to 2009 and the 2010 census data, for the 
2010–2013 period10. Due to the lack of data on the population distribution by municipalities 
in 2013, the geographic distribution and spatial analysis in the post-vaccination period 
was restricted to 2011–2012. Data from the Information System on Live Birth (SINASC 
– Sistema de Informação de Nascidos Vivos) was used to calculate the PM incidence rate 
in children < 1 year old, in 20137. 
Spatial Analyses
Spatial analysis used a Geographic Information System (GIS) (SIRGAS 2000 datum) for 
spatial data representation, in which the estimated PM incidence rates in under-5 children, 
vaccine coverage, and socioeconomic variables were associated with the spatial data.
The PM incidence rates were analyzed by São Paulo municipalities and micro-regions. 
These data, together with data on vaccination coverage and socioeconomic variables, 
were used to prepare the thematic maps with QGIS 2.6.1 software, using the IBGE 
cartographic base11,12.
To detect spatial and spatiotemporal clusters of PM cases, São Paulo municipalities were 
used as ecological units of analysis through the scan statistic technique, using SaTScan 
9.2TM, and the significance of the clusters found was evaluated through the likelihood ratio 
test, obtained through Monte Carlo simulation13,14.
Relative risk (RR) allows one to compare information from different areas, unifying and 
removing the effect of distinct populations, showing the intensity of the occurrence of 
a given phenomenon regarding all other regions studied, being considered significant 
at p < 0.05.
The number of PM cases per São Paulo micro-region was modeled through a Besag-York-Mollié 
model, using a zero-inflated Poisson regression and considering minimally informative 
priors through software R version 3.3.2 with the integrated nested Laplace approximation 
(INLA) package15–17.
Each IPRS dimension was considered a covariant in the analysis of PM incidence rates from 
2005 to 2009 and from 2011 to 2012. The analysis unit was each São Paulo micro-region. 
To investigate the relationship between PM occurrence and the covariates of interest, 
a Bayesian inference for latent Gaussian model was used, using a zero-inflated Poisson 
model due to the excess of analyzed units with zero cases. The INLA methodology, which 
is an alternative to the Markov chain Monte Carlo, was used in the model since this is 
computationally more efficient for the type of modeling used in this study15–17.
RESULTS
From January 2005 to December 2013, 3,963 PM cases were reported in São Paulo. Total 
incidence rates remained stable throughout the study period (1/100,000 inhabitants 
in 2005 to 1.06/100,000 in 2013), and the highest rates occurred among infants. In the 
post-vaccination period, there was a decrease in PM incidence rates in under-5 children, 
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Table 1. Pneumococcal meningitis incidence rates (per 100,000 inhabitants), by year of occurrence 
and age group. São Paulo, Brasil, 2005 to 2013a. 
Age group
Year
2005 2006 2007 2008 2009 2010b 2011 2012 2013
< 1 13.11 16.11 15.30 14.50 14.38 13.13 8.69 8.45 8.51
1–4 1.99 2.11 2.29 2.60 1.92 2.24 1.64 1.54 0.98
5–9 0.75 1.17 0.98 0.44 0.83 1.01 0.94 0.93 0.60
10–14 0.40 0.62 0.42 0.30 0.54 0.57 0.75 0.74 0.65
15–19 0.38 0.58 0.35 0.47 0.27 0.58 0.78 0.45 0.41
20–29 0.48 0.61 0.33 0.44 0.38 0.66 0.64 0.32 0.69
30–39 0.54 0.78 0.66 0.61 0.57 0.77 0.82 0.80 0.70
40–49 0.80 0.83 0.61 0.91 0.84 1.12 1.37 1.20 1.38
50–59 1.40 1.27 1.04 1.69 0.82 1.58 1.70 1.74 1.49
60–69 1.13 1.60 1.30 1.09 0.82 1.32 1.76 1.68 1.42
70–79 1.50 1.26 0.91 0.88 1.14 0.75 1.43 1.22 1.31
> 80 1.21 0.56 1.07 0.84 0.64 1.35 1.19 1.33 1.62
Total 1.00 1.16 0.96 1.02 0.88 1.15 1.20 1.07 1.06
a 65 cases without age group information.
b Year of PCV10 introduction.
Figure 1. Pneumococcal meningitis incidence rate (per 100,000 inhabitants), by age group and year of 
occurrence. São Paulo, Brazil, 2005–2013.
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Table 2. Distribution (%) of pneumococcal meningitis (PM) cases in infants, by age group and year of 
occurrence. São Paulo, 2005–2013.
Year/%
Group age (months)
< 2 2 ⱶ 4 4 ⱶ 6 6 ⱶ 12 
2005 15.56 21.11 11.11 52.22
2006 16.30 18.48 28.26 36.96
2007 22.09 13.95 23.26 40.70
2008 6.25 26.25 15.00 52.50
2009 21.79 15.38 15.38 47.44
2010 24.29 20.00 24.29 31.43
2011 32.65 20.41 22.45 24.49
2012 31.25 31.25 12.50 25.00
2013 23.08 40.38 13.46 23.08
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particularly in infants (from 13.1/100,000 in 2005 and 14.38/100,000 in 2009 to 8.69/100,000 in 
2011). There was a trend towards higher PM incidence rates among adults over 50 years old, 
albeit to a lesser extent than the drop in incidence rates in children (Table 1 and Figure 1).
In the pre-vaccination period (2005–2009), most PM cases among infants occurred 
in those aged from six to 12 months. After vaccination, the proportion of cases in the 
IPRS: São Paulo Index of Social Responsibility
Figure 2. Distribution of pneumococcal meningitis (PM) incidence rates in under-5 children (per 100,000 inhabitants), before (A) and 
after (B) introduction of 10-valent pneumococcal vaccine (PCV10) in childhood immunization; coverage (%) of the third PCV10 dose 
from 2011 to 2012 (C); socioeconomic variables wealth 263 (D), longevity (E), and schooling (F) in quintiles in 2010, by São Paulo 
state micro-regions.
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second semester of life decreased, with most cases occurring in the first four months 
of life. In 2013, more than 40% of cases in infants occurred in those two to four months 
old (Table 2).
The distribution of annual PM incidence rates in under-5 children was 4.8/100,000 
inhabitants-year in the pre-vaccination period and 2.9/100,000 inhabitants-year in the 
post-vaccination period, with a large variation among municipalities. In the city of São Paulo, 
annual PM incidence rates in under-5 children were 6.9 and 3.7/100,000 inhabitants-year 
in the pre- and post-vaccination periods, respectively.
In all age groups, PM cases occurred in 264 out of 645 municipalities from 2005 to 2009, 
and in 185 from 2011 to 2013. Considering only cases in under-5 children, just 145 and 
63 municipalities reported PM cases in the two periods, respectively. The large number of 
municipalities with zero cases impaired the analysis of PM incidence rates distribution. 
Therefore, the analysis was performed by micro-regions (Figure 2) since aggregating data 
in larger geographic areas allows for a better visualization.
Scan statistics was used to detect spatial clusters of municipalities with higher or lower 
RR and higher or lower PM incidence rate (Figure 3). Two clusters were observed in the 
pre-vaccination period (Figure 3, A). The first one, with a RR = 1.62 (p = 0.0000) for PM 
incidence, included 39 municipalities in the southeast of the state (including São Paulo city, 
with 1,166,547 under-5 children and PM incidence rate of 6.5/100,000/year). The second 
cluster, with a RR = 0.45 (p = 0.0003) for PM incidence, included 306 municipalities in the 
northwest of the state, with a population of 336,865 under-5 children and PM incidence 
rate of 2.5/100,000/year.
Only one cluster, albeit not a significant one, of higher PM incidence rate (RR = 1.97 and 
p = 0.0570) was observed in the post-vaccination period, comprising 47 municipalities 
(including São Paulo city) with a population of 1,310,494 under-5 children and PM incidence 
rate of 4.1/100,000/year (Figure 3, B).
The relationship between PM incidence rates in under-5 children and the covariates 
of wealth, longevity, education level and vaccination coverage were analyzed for each 
micro-region (Table 3). The odds of zero-PM cases were 0.517 in the pre-vaccination 
period and 0.601 in the post-vaccination period. Prior to vaccination, the IPRS wealth 
variable was positively associated with PM occurrence (RR = 1,026; 95%CI 1,002–1,052), 
whereas in the post-vaccination period none of the IPRS covariates were associated 
with PM occurrence.
Figure 3. Spatial clusters of the mean annual pneumococcal meningitis (PM) incidence rates in under-5 children (per 100,000 inhabitants), 
by São Paulo state municipalities, in the pre- (2005–2009) (A) and post-vaccination (2011–2012) (B) periods.
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DISCUSSION
In São Paulo, during the entire studied period (2005–2013), the highest PM incidence rates 
occurred in under-5 children, mainly in infants. A reduction in PM incidence rates was 
observed in the post-vaccination period. Thematic maps showed higher PM incidence 
rates among under-5 children in São Paulo micro-regions with higher wealth index in 
the pre-vaccination period. This effect disappeared in the post-vaccination period. In the 
pre-vaccination period, two clusters were found, one of low PM risk in the northwest of the 
state, and one of high risk in the southeast region, which includes São Paulo city. Only the 
latter cluster persisted in the post-vaccination period. In the Bayesian model analysis, only 
wealth was positively associated to PM in before the vaccination period.
The observed reduction in PM incidence rates in under-5 children, two years after the PCV10 
introduction, is similar to results of other Brazilian studies, as well as those observed in other 
countries after pneumococcal conjugate vaccines introduction18–22. The reduction from 56% 
to 69% in IPD incidence rates, including meningitis, in children younger than two years of 
age was observed after 7-valent pneumococcal conjugate vaccine (PCV7) introduction in 
the United States and Australia23,24. 
In São Paulo, from 2010 to 2013, PCV10 primary vaccination was administered to children 
at three, five, and seven months of age. After the vaccination program implementation, 
the greatest reduction in PM incidence rates occurred among infants aged from six to 
twelve months, who must have already completed the primary vaccination schedule. In the 
post-vaccination period, more than 40% of PM cases in infants occurred in those aged from 
two to four months. In 2014, in face of these changes in PM pattern, São Paulo has modified 
the vaccination schedule and started administering PCV10 at two, four and six months of 
age, like the rest of the country. In 2016, a 2+1 schedule was adopted in Brazil25. A Brazilian 
case-control study showed an effectiveness of 81.3% for one PCV10 dose and of 95.5% for 
three PCV10 doses in protecting against IPD caused by the vaccine serotypes26. 
Our results did not show a decrease in PM incidence rates in older age groups that are 
not target for vaccination, corroborating the findings of other studies. Two retrospective 
studies using hospital data failed to detect a significant effect on IPD incidence in 
unvaccinated populations two years after PCV10 introduction27,28. No decrease on IPD 
was observed in unvaccinated individuals from 2 to 17 years old, whereas an increase 
was observed in adults aged ≥ 18 years, in an interrupted time series analysis using data 
from the National Reference Laboratory (all IPD cases) and SINAN (only PM cases), 
adjusted for seasonality and temporal trends, in the pre- (2008–2009) and post-vaccination 
(2011–2013) periods19. A review of the impact of PCV10 in Brazil found inconsistent data 
regarding herd protection29. 
Table 3. Bayesian Besag-York-Mollié model (zero-inflated Poisson) for pneumococcal meningitis 
incidence rates in under-5 children and relationship with the covariates wealth, longevity, schooling 
and vaccination coverage, in the pre- (2005–2009) and post-vaccination (2011–2012) periods, by São 
Paulo state micro-regions.
Variable
Covariables model
2005–2009 2011–2012
Mean* Qt 0.025 Qt 0.975 Mean* Qt 0.025 Qt 0.975
p (0) 0.517 0.462 0.572 0.601 0.515 0.684
Intercept 0.647 0.112 3.561 0.249 0.008 6.718
Wealth 1.026 1.002 1.052 1.031 0.988 1.078
Longevity 0.995 0.963 1.030 1.008 0.953 1.072
Schooling 0.992 0.968 1.016 0.986 0.952 1.020
Vaccination coverage - - - 1.001 0.995 1.007
* Except for p = 0, which is the probability of zero, the mean represents the relative risk.
Qt: 95% credibility interval.
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After pneumococcal conjugate vaccines introduction in routine childhood immunization 
programs, the decline on overall IPD in under-5 children is substantial and consistent 
amongst different studies. Reduction of IPD rates in older age groups that are not target of 
vaccination (indirect effects) has been more variable and subject of debate30,31. The indirect 
effects of PCV childhood immunization may vary from place to place according to disease 
epidemiology before vaccine introduction (incidence rates, serotype distribution), vaccination 
program characteristics (which vaccine is used, number of doses in the primary schedule, 
vaccine coverage, catch-up implementation), and the degree of pneumococcal serotypes 
replacement. Longer observation time may be required to detect the indirect effects of 
vaccination32. A meta-analysis of the impact of pneumococcal vaccination programs found 
that seven to 10 years may be necessary to achieve substantial herd protection31. In addition, 
in places with a low burden of disease, adult pneumococcal colonization is rare and the 
childhood vaccination program has a major impact on pneumococcal transmission in the 
community. On the other hand, in places with a higher burden of disease, adults are more 
frequently colonized and may have greater role in transmission and, consequently, the 
indirect effects of childhood vaccination program may be more limited33.
In our study, the PM incidence rate was positively associated to wealth, which was 
unexpected. Data from different countries showed that crowded living conditions, less 
education, and lower socioeconomic status are risk factors for pneumococcal disease1. 
Although blood and cerebral spinal fluid cultures are considered the standard for PM 
diagnosis, their sensitivity is limited. Prior antibiotic use and improper clinical specimens’ 
handling or transport may jeopardize culture results. More sensitive tests, based on 
molecular techniques and pneumococcal antigens detection, are available34–36. In São 
Paulo, the first state to introduce PCR in public health laboratories, the proportion of 
bacterial meningitis of unknown etiology decreased from approximately 50% in the 
beginning of the 2000s to about 25% in 2010–2013. The incorporation of real-time PCR into 
routine microbiological methods increased pneumococcal detection by 52%37. The use of 
immune-chromatography test (ICT) for pneumococcal antigens in meningitis diagnoses 
also increases pneumococcal detection in blood and cerebral spinal fluid, particularly in 
the case of previous antibiotic use36. However, the use of PCR and ICT for pneumococcal 
antigen is limited in clinical practice. In Brazil, although PCR is already available in central 
public health laboratories (LACEN) in some Brazilian states such as São Paulo, its use in 
clinical practice is still limited to more developed regions, larger laboratories, and some 
university hospitals.
As described above, rates of bacterial meningitis cases with a definitive etiological diagnosis 
have increased progressively from 36.4% in 2005 to 53.2% in 2013, mainly due to PCR 
incorporation in meningitis diagnosis; however, the current rates are still low. Even the 
cytological examination of blood and cerebral spinal fluid was performed in only 65.4% of 
cases in 2013, without an increase in this rate in recent years38. Additionally, medical practice 
regarding blood cultures collection also varies in different regions and health services.
SINAN, the data source for this study, is a passive system, dependent on technical operation 
conditions of the epidemiological and laboratory surveillance system of each geographical 
area to detect, notify, investigate, and perform specific laboratory tests for the etiological 
diagnosis of bacterial meningitis. Underreporting is an issue. A meningitis study conducted 
in Belo Horizonte, in the state of Minas Gerais, in Southeastern Brazil, showed that SINAN 
data was not complete, with an estimated sensitivity of 66% for all-causes meningitis39. This 
is the main limitation of our data.
Consequently, PM is probably underdiagnosed and underreported in Brazil. Brazil is a 
huge country with great regional socioeconomic differences. The State of São Paulo also 
has regional differences, with areas of lower socioeconomic development. Our hypothesis 
is that the proper PM diagnosis and reporting is not equally distributed in different regions 
– wealthy areas with better access to health care, better laboratory structure, greater use of 
9Spatial analysis of pneumococcal meningitis in São Paulo Oliveira DS et al.
https://doi.org/10.11606/S1518-8787.2019053001183
more sensitive diagnostic tests and better surveillance have greater proportion of reported 
cases of meningitis with definitive etiological diagnosis. Furthermore, the proportion of 
meningitis cases with unknown etiology may be greater in less developed areas. These 
regional differences might explain the association found between PM rates and wealth.
The coverage of the third PCV10 dose increased quickly after vaccine introduction in Brazil, 
from 24% in 2010 to 93% in 2013. However, vaccine coverage rates varied by municipality, 
as showed in our thematic maps. Coverage rates were satisfactory and homogeneous, with 
all micro-regions presenting vaccine coverage > 75%. This could explain why vaccination 
coverage was not important in the Bayesian model analysis for the PM incidence rates in 
under-5 children by São Paulo micro-regions.
Surveillance data used in this study did not identify pneumococcal serotypes; thus, we could 
not evaluate the impact of vaccination on the PM cases caused by vaccine and non-vaccine 
serotypes. Despite the limitations, there are many reasons for using ecological studies in 
epidemiology, among which we highlight the low cost of working with secondary data and 
the interest in ecological effects40.
Health scenarios designed by geoprocessing techniques add socioeconomic, environmental 
and structural health data to the geographic component. The spatial correlation of data allows 
for planning strategic interventions in a given geographic area, through the characterization 
of regional scenarios41. The spatial statistical analysis carried out in this study contributes to 
the evaluation of PM cases and clusters in São Paulo. We highlight the methodology used to 
evaluate the associations between PM and socioeconomic variables. Although the Poisson 
model is used in studies to map diseases, it may be inappropriate in some applications due 
to the excess of zeros in the data compared to what is expected for the model – a situation 
found in this study. To deal with this scenario, we employ a zero-inflated model that allowed 
modeling with consistent results42. Modeling spatiotemporal epidemiological data with 
excess zeros requires Bayesian methods, which generally demand a number of inferential 
processes, generating excessive computational time. In this study, we highlight the use of 
the INLA method proposed by Rue et al.15 This method allowed us to analyze PM cases 
considering the above conditions with an expressive computational gain, enabling several 
models to be adjusted and several scenarios to be explored to solve this problem, which 
would not be possible in models that did not simultaneously incorporate zero counts and 
spatiotemporal structure42. 
Results of this study emphasize the need to invest in the meningitis diagnostic capacity in 
Brazil, to improve the quality of disease surveillance and recording and to optimize vaccine 
coverage in regions with low coverage.
Further studies are required to monitor pneumococcal disease epidemiology, the effects 
of PCV10 introduction, and the pneumococcal serotypes distribution in the Brazilian 
population. Studying smaller ecological units would also reduce the effect of relative 
over-dispersion and facilitate interventions in geographically smaller areas and in those 
areas of higher risk.
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